Berdeja, Jesus G: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

1

Ibrutinib alone or with dexamethasone for relapsed or relapsed and refractory multiple myeloma: phase 2 trial results

Richardson, Paul G., Bensinger, William I., Huff, Carol Ann, Costello, Caitlin L., Lendvai, Nikoletta, Berdeja, Jesus G., Anderson, Larry D., Siegel, David S., Lebovic, Daniel, Jagannath, Sundar, Laub

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 180 KB

english, 2018

2

Open-Label Study to Determine the Feasibility of Ixazomib as Maintenance after Allogeneic Stem Cell Transplant for Multiple Myeloma

Bachier, Carlos R., Shaughnessy, Paul J., Matous, Jeffrey, Berdeja, Jesus G.

Journal:

Biology of Blood and Marrow Transplantation

Year:

2018

Language:

english

File:

PDF, 196 KB

english, 2018

3

Ricolinostat plus lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: a multicentre phase 1b trial

Yee, Andrew J, Bensinger, William I, Supko, Jeffrey G, Voorhees, Peter M, Berdeja, Jesus G, Richardson, Paul G, Libby, Edward N, Wallace, Ellen E, Birrer, Nicole E, Burke, Jill N, Tamang, David L, Yan

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 390 KB

english, 2016

4

Anti-BCMA CAR T-Cell Therapy bb2121 in Relapsed or Refractory Multiple Myeloma

Raje, Noopur, Berdeja, Jesus, Lin, Yi, Siegel, David, Jagannath, Sundar, Madduri, Deepu, Liedtke, Michaela, Rosenblatt, Jacalyn, Maus, Marcela V., Turka, Ashley, Lam, Lyh-Ping, Morgan, Richard A., Fri

Journal:

New England Journal of Medicine

Year:

2019

Language:

english

File:

PDF, 506 KB

english, 2019

5

Ixazomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma: long-term follow-up including ixazomib maintenance

Kumar, Shaji K., Berdeja, Jesus G., Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob P., Hamadani, Mehdi, Stewart, A. Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan L., Berg,

Journal:

Year:

2019

Language:

english

File:

PDF, 1.07 MB

english, 2019

6

Carfilzomib (CFZ, Kyprolis®), Lenalidomide (LEN, Revlimid®), and Dexamethasone (DEX) (KRd) Combined with Autologous Stem Cell Transplant (ASCT) Shows Improved Efficacy Compared with Krd without ASCT in Newly Diagnosed Multiple Myeloma (NDMM)

Zimmerman, Todd M., Griffith, Kent, Jasielec, Jagoda K., Rosenbaum, Cara A., Berdeja, Jesus G., Vij, Ravi, Raje, Noopur, Reece, Donna E., Vesole, David H., Jagannath, Sundar, Kaminski, Mark, Cole, Cra

Journal:

Biology of Blood and Marrow Transplantation

Year:

2016

Language:

english

File:

PDF, 116 KB

english, 2016

7

Deep and Durable Responses with Weekly Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Follow-up of Patients Not Undergoing Stem Cell Transplantation (SCT)

Kumar, Shaji, Berdeja, Jesus, Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob, Hamadani, Mehdi, Stewart, A. Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan, Berg, Deborah, Lia

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 82 KB

english, 2017

8

The DOT1L inhibitor pinometostat reduces H3K79 methylation and has modest clinical activity in adult acute leukemia

Stein, Eytan M., Garcia-Manero, Guillermo, Rizzieri, David A., Tibes, Raoul, Berdeja, Jesus G., Savona, Michael R., Jongen-Lavrenic, Mojca, Altman, Jessica K., Thomson, Blythe, Blakemore, Stephen J.,

Journal:

Year:

2018

Language:

english

File:

PDF, 635 KB

english, 2018

9

Lorvotuzumab mertansine: antibody-drug-conjugate for CD56⁺ multiple myeloma

Journal:

Frontiers in Bioscience

Year:

2014

Language:

english

File:

PDF, 241 KB

english, 2014

10

Phase I study of MLN8237—investigational Aurora A kinase inhibitor—in relapsed/refractory multiple myeloma, Non-Hodgkin lymphoma and chronic lymphocytic leukemia

Kelly, Kevin R., Shea, Thomas C., Goy, André, Berdeja, Jesus G., Reeder, Craig B., McDonagh, Kevin T., Zhou, Xiaofei, Danaee, Hadi, Liu, Hua, Ecsedy, Jeffrey A., Niu, Huifeng, Benaim, Ely, Padmanabhan

Journal:

Investigational New Drugs

Year:

2014

Language:

english

File:

PDF, 542 KB

english, 2014

11

Safety and tolerability of ixazomib, an oral proteasome inhibitor, in combination with lenalidomide and dexamethasone in patients with previously untreated multiple myeloma: an open-label phase 1/2 study

Kumar, Shaji K, Berdeja, Jesus G, Niesvizky, Ruben, Lonial, Sagar, Laubach, Jacob P, Hamadani, Mehdi, Stewart, A Keith, Hari, Parameswaran, Roy, Vivek, Vescio, Robert, Kaufman, Jonathan L, Berg, Debor

Journal:

The Lancet Oncology

Year:

2014

Language:

english

File:

PDF, 178 KB

english, 2014

12

Twice-weekly ixazomib in combination with lenalidomide-dexamethasone in patients with newly diagnosed multiple myeloma

Richardson, Paul G., Hofmeister, Craig C., Rosenbaum, Cara A., Htut, Myo, Vesole, David H., Berdeja, Jesus G., Liedtke, Michaela, Chari, Ajai, Smith, Stephen D., Lebovic, Daniel, Raje, Noopur, Byrne,

Journal:

British Journal of Haematology

Year:

2018

Language:

english

File:

PDF, 270 KB

english, 2018

13

A phase 1b study of onceâweekly carfilzomib combined with lenalidomide and dexamethasone in patients with newly diagnosed multiple myeloma

Alsina, Melissa, Landgren, Ola, Raje, Noopur, Niesvizky, Ruben, Bensinger, William I., Berdeja, Jesus G., Kovacsovics, Tibor, Vesole, David H., Fang, Belle, Kimball, Amy S., Siegel, David S.

Journal:

American Journal of Hematology

Year:

2020

File:

PDF, 1.30 MB

2020

14

Bendamustine, bortezomib and rituximab produces durable complete remissions in patients with previously untreated, low grade lymphoma

Flinn, Ian W., Thompson, Dana S., Boccia, Ralph V., Miletello, Gerald, Lipman, Andrew, Flora, Douglas, Cuevas, Daniel, Papish, Steven W., Berdeja, Jesus G.

Journal:

British Journal of Haematology

Year:

2017

Language:

english

File:

PDF, 301 KB

english, 2017

15

Sotatercept with long-term extension for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes: a phase 2, dose-ranging trial

Komrokji, Rami, Garcia-Manero, Guillermo, Ades, Lionel, Prebet, Thomas, Steensma, David P, Jurcic, Joseph G, Sekeres, Mikkael A, Berdeja, Jesus, Savona, Michael R, Beyne-Rauzy, Odile, Stamatoullas, As

Journal:

The Lancet Haematology

Year:

2018

Language:

english

File:

PDF, 327 KB

english, 2018

16

A Phase II Trial Evaluating the Safety of Rapid Infusion of Ofatumumab in Patients with Previously Treated Chronic Lymphocytic Leukemia

Donnellan, William, Berdeja, Jesus G., Shipley, Diana, Arrowsmith, Edward R., Wright, David, Lunin, Scott, Brown, Richard, Essell, James H., Flinn, Ian W.

Journal:

Year:

2017

Language:

english

File:

PDF, 304 KB

english, 2017

17

A Global Treatment Standard in Multiple Myeloma (MM) Remains Elusive Despite Advances in Care over 15 years: First Results from INSIGHT MM, the Largest Global Prospective, Observational MM Study

Costello, Caitlin, Boccadoro, Mario, Usmani, Saad Z., Chari, Ajai, Rifkin, Robert M., Abonour, Rafat, Berdeja, Jesus, Cook, Gordon, Goldschmidt, Hartmut, Hajek, Roman, Hungria, Vania, Lee, Hans C., Le

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 87 KB

english, 2018

18

An Open-Label Phase 2 Study of Carfilzomib plus Dexamethasone to Assess Tolerability and Adherence in Patients with Relapsed or Refractory Multiple Myeloma at US Community Oncology Centers

Fonseca, Rafael, Alsina, Melissa, Berdeja, Jesus, Heitner, Stephen B., Morris, Christopher, Khurana, Monica, Niesvizky, Ruben

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2018

Language:

english

File:

PDF, 93 KB

english, 2018

19

Integrated safety profile of selinexor in multiple myeloma: experience from 437 patients enrolled in clinical trials

Gavriatopoulou, Maria, Chari, Ajai, Chen, Christine, Bahlis, Nizar, Vogl, Dan T., Jakubowiak, Andrzej, Dingli, David, Cornell, Robert F., Hofmeister, Craig C., Siegel, David, Berdeja, Jesus G., Reece,

Journal:

Year:

2020

Language:

english

File:

PDF, 1.37 MB

english, 2020

20

5.30 Preliminary Results from a Phase I/II Study of Fludarabine (F), Rituximab (R), and Lenalidomide (L) in Untreated Patients with Chronic Lymphocytic Leukemia (CLL)

Ian W. Flinn, Ines M. Macias-Perez, Patrick S. Tucker, R. Seth Cooper, Habib H. Doss, Dana S. Thompson, Jesus G. Berdeja, John D. Hainsworth

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2011

Language:

english

File:

PDF, 95 KB

english, 2011

21

Single-Arm, Phase 2 Study of Elotuzumab in Combination With Pomalidomide and Dexamethasone in Patients With Multiple Myeloma Who Are Relapsed/Refractory to Lenalidomide: Initial Safety Data

Jagannath, Sundar, Berdeja, Jesus, Rifkin, Robert, Cole, Craig, Thompson, Michael A., Ricafort, Rosanna J., Scofield, Amanda, Mohamed, Hesham, Sy, Oumar, Vij, Ravi, Bensinger, William

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 64 KB

english, 2017

22

Pevonedistat, a first-in-class NEDD8-activating enzyme (NAE) inhibitor, combined with azacitidine, in patients with AML

Swords, Ronan T., Coutre, Steven, Maris, Michael B., Zeidner, Joshua F., Foran, James M., Cruz, Jose, Erba, Harry P., Berdeja, Jesus G., Tam, Wayne, Vardhanabhuti, Saran, Pawlikowska-Dobler, Iwona, Fa

Journal:

Year:

2018

Language:

english

File:

PDF, 473 KB

english, 2018

23

A Phase 1b/2 Study of Oprozomib in Patients With Advanced Multiple Myeloma and Waldenström Macroglobulinemia

Ghobrial, Irene M., Vij, Ravi, Siegel, David S., Badros, Ashraf Z, Kaufman, Jonathan L, Raje, Noopur S, Jakubowiak, Andrzej J., Savona, Michael R., Obreja, Mihaela, Berdeja, Jesus G

Journal:

Clinical Cancer Research

Year:

2019

Language:

english

File:

PDF, 1.41 MB

english, 2019

24

TAK-228 (formerly MLN0128), an investigational oral dual TORC1/2 inhibitor: A phase I dose escalation study in patients with relapsed or refractory multiple myeloma, non-Hodgkin lymphoma, or Waldenström's macroglobulinemia

Ghobrial, Irene M., Siegel, David S., Vij, Ravi, Berdeja, Jesus G., Richardson, Paul G., Neuwirth, Rachel, Patel, Chirag G., Zohren, Fabian, Wolf, Jeffrey L.

Journal:

American Journal of Hematology

Year:

2016

Language:

english

File:

PDF, 522 KB

english, 2016

25

New approaches to blood and marrow transplantation for patients with low-grade lymphomas

Berdeja, Jesús G., Flinn, Ian W.

Journal:

Current Opinion in Oncology

Year:

2001

Language:

english

File:

PDF, 82 KB

english, 2001

26

Weekly carfilzomib, lenalidomide, and dexamethasone in relapsed or refractory multiple myeloma: A phase 1b study

Biran, Noa, Siegel, David, Berdeja, Jesus G., Raje, Noopur, Cornell, R. Frank, Alsina, Melissa, Kovacsovics, Tibor, Fang, Belle, Kimball, Amy S., Landgren, Ola

Journal:

American Journal of Hematology

Year:

2019

Language:

english

File:

PDF, 814 KB

english, 2019

27

Efficacy and Safety of Once-Weekly Carfilzomib and Dexamethasone in Patients With Relapsed or Refractory Multiple Myeloma: Secondary Analysis from the CHAMPION-1 Study by Prior Lines of Therapy

Berdeja, Jesus, Rifkin, Robert, Lyons, Roger, Cartmell, Alan, Coleman, Morton, Yang, Hui, Zahlten-Kumeli, Anita, Iskander, Karim, Berenson, James

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 84 KB

english, 2017

28

Combination trial of duvelisib (IPI‐145) with rituximab or bendamustine/rituximab in patients with non‐Hodgkin lymphoma or chronic lymphocytic leukemia

Flinn, Ian W., Cherry, Mohamad A., Maris, Michael B., Matous, Jeffrey V., Berdeja, Jesus G., Patel, Manish

Journal:

American Journal of Hematology

Year:

2019

Language:

english

File:

PDF, 1.67 MB

english, 2019

29

Safety, tolerability, and preliminary activity of CUDC-907, a first-in-class, oral, dual inhibitor of HDAC and PI3K, in patients with relapsed or refractory lymphoma or multiple myeloma: an open-label, dose-escalation, phase 1 trial

Younes, Anas, Berdeja, Jesus G, Patel, Manish R, Flinn, Ian, Gerecitano, John F, Neelapu, Sattva S, Kelly, Kevin R, Copeland, Amanda R, Akins, Amy, Clancy, Myles S, Gong, Lucy, Wang, Jing, Ma, Anna, V

Journal:

The Lancet Oncology

Year:

2016

Language:

english

File:

PDF, 553 KB

english, 2016

30

Global, Prospective, Non-interventional, Observational Study of Disease Presentation, Treatment Patterns, and Outcomes in Multiple Myeloma (MM) Patients (pts): The INSIGHT MM Study (NCT02761187)

Rifkin, Robert, Davies, Faith, Palumbo, Antonio, Zonder, Jeffrey A., Girnius, Saulius, Costello, Caitlin, Usmani, Saad, Berdeja, Jesus, Omel, Jim, Thompson, Michael, Schwartz, J Sanford, Hajek, Roman,

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 72 KB

english, 2017

31

Phase 1 study of the protein deubiquitinase inhibitor VLX1570 in patients with relapsed and/or refractory multiple myeloma

Rowinsky, Eric K., Paner, Agne, Berdeja, Jesus G., Paba-Prada, Claudia, Venugopal, Parameswaran, Porkka, Kimmo, Gullbo, Joachim, Linder, Stig, Loskog, Angelica, Richardson, Paul G., Landgren, Ola

Journal:

Investigational New Drugs

Year:

2020

File:

PDF, 261 KB

2020

32

Phase 2, randomized, double-blind study of pracinostat in combination with azacitidine in patients with untreated, higher-risk myelodysplastic syndromes

Garcia-Manero, Guillermo, Montalban-Bravo, Guillermo, Berdeja, Jesus G., Abaza, Yasmin, Jabbour, Elias, Essell, James, Lyons, Roger M., Ravandi, Farhad, Maris, Michael, Heller, Brian, DeZern, Amy E.,

Journal:

Year:

2017

Language:

english

File:

PDF, 267 KB

english, 2017

33

First-in-Human Phase 1 Study of ABBV-838, an Antibody-Drug Conjugate Targeting SLAMF7/CS1 in Patients With Relapsed and Refractory Multiple Myeloma

Vij, Ravi, Nath, Rajneesh, Afar, Daniel E.H., Mateos, Maria Victoria, Berdeja, Jesus G, Raab, Marc S, Guenther, Andreas, Martinez-Lopez, Joaquin, Jakubowiak, Andrzej J., Leleu, Xavier, Weisel, Katja,

Journal:

Clinical Cancer Research

Year:

2020

Language:

english

File:

PDF, 2.29 MB

english, 2020

34

Phase II study of bendamustine, bortezomib and dexamethasone (BBD) in the first-line treatment of patients with multiple myeloma who are not candidates for high dose chemotherapy

Berdeja, Jesus G., Bauer, Todd, Arrowsmith, Edward, Essell, James, Murphy, Patrick, Reeves, James A., Boccia, Ralph V., Donnellan, William, Flinn, Ian

Journal:

British Journal of Haematology

Year:

2017

Language:

english

File:

PDF, 405 KB

english, 2017

35

Health-Related Quality of Life With Pomalidomide + Dexamethasone + Daratumumab After Lenalidomide in Relapsed or Refractory Multiple Myeloma Patients

Reece, Donna, Bahlis, Nizar J., Samaras, Christy Joy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Acosta-Rivera, Mirelis

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 85 KB

2019

36

Allogeneic bone marrow transplantation in patients with sensitive low-grade lymphoma or mantle cell lymphoma

Jesüs G. Berdeja, Richard J. Jones, Marianna L. Zahurak, Steven Piantadosi, Ross A. Abrams, Michael J. Borowitz, Georgia B. Vogelsang, Stephen J. Noga, Richard F. Ambinder, Ian W. Flinn

Journal:

Biology of Blood and Marrow Transplantation

Year:

2001

Language:

english

File:

PDF, 125 KB

english, 2001

37

Carfilzomib, lenalidomide, and dexamethasone plus transplant in newly diagnosed multiple myeloma

Jasielec, Jagoda, Kubicki, Tadeusz, Raje, Noopur, Vij, Ravi, Reece, Donna, Berdeja, Jesus G, Derman, Benjamin, Rosenbaum, Cara A, Richardson, Paul G, Gurbuxani, Sandeep, Major, Sarah, Wolfe, Brittany,

Journal:

Year:

2020

File:

PDF, 2.42 MB

2020

38

Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study

Berdeja, Jesus, Jagannath, Sundar, Zonder, Jeffrey, Badros, Ashraf, Kaufman, Jonathan L., Manges, Robert, Gupta, Manish, Tendolkar, Amol, Lynch, Mark, Bleickardt, Eric, Paliwal, Prashni, Vij, Ravi

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2015

Language:

english

File:

PDF, 431 KB

english, 2015

39

A tale of two paradigms: fixed duration vs continuous therapy in routine clinical practice: An INSIGHT MM study analysis of duration of therapy

Weisel, Katja, Hungria, Vania, Leleu, Xavier, Lee, Hans, Rifkin, Robert, Costello, Caitlin, Abonour, Rafat, Chari, Ajai, Puig, Noemi, Berdeja, Jesus, Cook, Gordon, Thompson, Michael A., Boccadoro, Mar

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 90 KB

english, 2019

40

Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myeloma

Dhakal, Binod, DâSouza, Anita, Callander, Natalie, Chhabra, Saurabh, Fraser, Raphael, Davila, Omar, Anderson, Kenneth, Assal, Amer, Badawy, Sherif M., Berdeja, Jesus, Cerny, Jan, Comenzo, Raymond, C

Journal:

British Journal of Haematology

Year:

2020

File:

PDF, 643 KB

2020

41

Single-Arm, Phase 2 Study of Elotuzumab in Combination With Pomalidomide and Dexamethasone in Patients With Multiple Myeloma Who Are Relapsed/Refractory to Lenalidomide: Initial Safety Data

Jagannath, Sundar, Berdeja, Jesus, Rifkin, Robert, Cole, Craig, Thompson, Michael A., Ricafort, Rosanna J., Scofield, Amanda, Mohamed, Hesham, Sy, Oumar, Vij, Ravi, Bensinger, William

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 87 KB

english, 2017

42

INSIGHT MM: a large, global, prospective, non-interventional, real-world study of patients with multiple myeloma

Costello, Caitlin, Davies, Faith E, Cook, Gordon, Vela-Ojeda, Jorge, Omel, Jim, Rifkin, Robert M, Berdeja, Jesus, Puig, Noemi, Usmani, Saad Z, Weisel, Katja, Zonder, Jeffrey A, Terpos, Evangelos, Spen

Journal:

Future Oncology

Year:

2019

Language:

english

File:

PDF, 1.68 MB

english, 2019

43

A Phase 1b/2 Study of Oprozomib in Patients With Advanced Multiple Myeloma and Waldenström Macroglobulinemia

Ghobrial, Irene M., Vij, Ravi, Siegel, David S., Badros, Ashraf Z, Kaufman, Jonathan L, Raje, Noopur S, Jakubowiak, Andrzej J., Savona, Michael R., Obreja, Mihaela, Berdeja, Jesus G

Journal:

Clinical Cancer Research

Year:

2019

File:

PDF, 1.41 MB

2019

44

Hodgkin Lymphoma-Like Posttransplant Lymphoproliferative Disorder (HL-Like PTLD) Simulates Monomorphic B-Cell PTLD Both Clinically and Pathologically

Pitman, Sean D., Huang, Qin, Zuppan, Craig W., Rowsell, Edward H., Cao, Jeffrey D., Berdeja, Jesus G., Weiss, Lawrence M., Wang, Jun

Journal:

American Journal of Surgical Pathology

Year:

2006

Language:

english

File:

PDF, 477 KB

english, 2006

45

A phase 1b study of once-weekly carfilzomib combined with lenalidomide and dexamethasone (wKRd) in patients (pts) with newly diagnosed multiple myeloma (NDMM)

Alsina, Melissa, Landgren, C. Ola, Raje, Noopur, Niesvizky, Ruben, Bensinger, William I., Berdeja, Jesus, Kovacsovics, Tibor, Vesole, David, Fang, Belle, Kimball, Amy, Siegel, David S.

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

File:

PDF, 66 KB

2019

46

A Network Approach to Standardization of BMT Pathways

McSweeney, Peter A., Bachier, Carlos, Berdeja, Jesus G., Safah, Hana, Elayan, Mohammed M., LeMaistre, Charles F., Billups, Rocky, Cox, Tonya

Journal:

Biology of Blood and Marrow Transplantation

Year:

2015

Language:

english

File:

PDF, 51 KB

english, 2015

47

A pharmacokinetics and safety phase 1/1b study of oral ixazomib in patients with multiple myeloma and severe renal impairment or end-stage renal disease requiring haemodialysis

Gupta, Neeraj, Hanley, Michael J., Harvey, R. Donald, Badros, Ashraf, Lipe, Brea, Kukreti, Vishal, Berdeja, Jesus, Yang, Huyuan, Hui, Ai-Min, Qian, Mark, Zhang, Xiaoquan, Venkatakrishnan, Karthik, Cha

Journal:

British Journal of Haematology

Year:

2016

Language:

english

File:

PDF, 235 KB

english, 2016

48

Twice-weekly Ixazomib plus Lenalidomide-dexamethasone (Rd) in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-term Follow-up Data for Patients Not Undergoing Stem Cell Transplantation (SCT)

Richardson, Paul, Hofmeister, Craig, Rosenbaum, Cara, Htut, Myo, Vesole, David, Berdeja, Jesus, Liedtke, Michaela, Chari, Ajai, Smith, Stephen, Lebovic, Daniel, Raje, Noopur, Liao, Eileen, Zhang, Xiao

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2017

Language:

english

File:

PDF, 71 KB

english, 2017

49

Oprozomib, pomalidomide, and dexamethasone in patients with relapsed and/or refractory multiple myeloma

Shah, Jatin, Usmani, Saad, Stadtmauer, Edward A., Rifkin, Robert M., Berenson, James R., Berdeja, Jesus G., Lyons, Roger M., Klippel, Zandra, Chang, Yu-Lin, Niesvizky, Ruben

Journal:

Clinical Lymphoma Myeloma and Leukemia

Year:

2019

Language:

english

File:

PDF, 1.79 MB

english, 2019

50

Pomalidomide, dexamethasone, and daratumumab in relapsed refractory multiple myeloma after lenalidomide treatment

Siegel, David S., Schiller, Gary J., Samaras, Christy, Sebag, Michael, Berdeja, Jesus, Ganguly, Siddhartha, Matous, Jeffrey, Song, Kevin, Seet, Christopher S., Talamo, Giampaolo, Acosta-Rivera, Mireli

Journal:

Year:

2020

File:

PDF, 665 KB

2020

To build up a library is to create a life. It’s never just a random collection of books.

— Carlos María Domínguez

Official channel

Z-Library Desktop Launcher

Z-Library Since 2009 support@1delivery.pm

EnglishРусскийEspañolItalianoελληνικάاللغة العربيةBahasa IndonesiaBahasa Malaysiaहिन्दीDeutschFrançaisPortuguêsУкраїнськаPolski中文繁體中文日本語Tiếng ViệtAzərbaycan DiliՀայոց լեզուภาษาไทยTürk Diliქართველიবাংলাپښتوతెలుగుاردو한국어SrpskiБългарски